Ting Therapeutics Advances TT004 into Phase Ib Clinical Trials as a Potential Cisplatin Chemoprotective Therapy

Oct 23, 2026

San Diego, California Oct 22, 2026 (Issuewire.com) - Ting Therapeutics Advances TT004 into Phase Ib Clinical Trial as a Potential Chemoprotective Therapy for Cisplatin-Treated Patients

  • China IND Approved;
  • Phase Ib Trial Set to Begin Recruiting Patients at Eye and ENT Hospital of Fudan University in Shanghai

Ting Therapeutics, Inc., a biotechnology company developing therapies for treatment-related tissue injury, today announced that its lead candidate, TT004, has received IND approval in China and is advancing into Phase Ib clinical development as a potential chemoprotective therapy for patients receiving cisplatin chemotherapy.

Cisplatin is a highly effective cancer treatment, but its toxicities can substantially limit therapy. Approximately 40% of patients discontinue or modify chemotherapy because of treatment-related toxicities. Cisplatin can also cause permanent hearing loss in up to 80% of patients and acute kidney injury in approximately 30% of patients.

TT004 is designed to protect normal tissues from cisplatin toxicity while preserving its anticancer activity. In preclinical studies, TT004 increased survival following cisplatin exposure three-fold and reduced cisplatin-induced hearing loss and kidney injury by approximately 70%, without compromising cisplatin's anticancer effects.

"These findings support our vision of TT004 as a chemoprotective therapy that could improve the tolerability of cisplatin while maintaining its anticancer efficacy," said Jian Zuo, PhD, Co-Founder and CEO of Ting Therapeutics. "Our goal is to reduce the suffering caused by cisplatin treatment-related toxicities, help more patients receive and complete effective chemotherapy, and improve their long-term quality of life."

Ting Therapeutics recently licensed its China rights for TT004 to Rising Dragon, a Chinese biotechnology company, for development in China. The companies jointly developed TT004 as an oral tablet and obtained IND approval from China's Center for Drug Evaluation (CDE) for first-in-human clinical evaluation.

The Phase Ib trial, conducted in collaboration with oncologists and otolaryngologists at Eye and ENT Hospital of Fudan University in Shanghai, will evaluate the safety and tolerability of oral TT004 administered with standard-of-care cisplatin chemotherapy in patients with head and neck cancer. The study has received institutional ethics approval and is preparing to initiate patient recruitment.

TT004's protective effects have been demonstrated only in preclinical models and have not yet been shown in humans. This trial is the first clinical evaluation of TT004 and an important step toward determining whether these effects can be translated to cancer patients.

About Ting Therapeutics

Founded in 2018, Ting Therapeutics, Inc. develops novel and repurposed therapeutics to prevent and treat hearing loss and other treatment-related tissue injuries. The Company's pipeline targets hearing loss associated with chemotherapy, noise exposure, antibiotics, aging, and other causes.

Contact:
Jian Zuo, PhD, Co-Founder & CEO
Ting Therapeutics, Inc.
6868 Nancy Ridge Dr., San Diego, CA 92121
[email protected]

Ting Therapeutics

 

Source :Ting Therapeutics, Inc.

This article was originally published by IssueWire. Read the original article here.

More News

Baco, Oriental Mindoro mayor dismissed from office
Oct 23, 2026
Baco, Oriental Mindoro mayor dismissed from office

CALAPAN CITY, Oriental Mindoro — The Department of the Interior and Local Government (DILG) Oriental Mindoro served the dismissal order issued by the Office of the Ombudsman against Baco, Oriental Mindoro Mayor Allan Roldan at around 5:00 p.m. on Thursday, Oct. 22. With the order served, Vice Mayor Eric Castillo has automatically assumed the position

[Market Rider] SEC’s market maker push and how it can boost PH stock trading
Oct 23, 2026
[Market Rider] SEC’s market maker push and how it can boost PH stock trading

SEC Chairman Francis Lim spearheads a daring undertaking into the realm of market making, in a bid to boost stock market trading in the Philippines

Tampakan forms task force to prepare for ‘Super El Niño’
Oct 22, 2026
Tampakan forms task force to prepare for ‘Super El Niño’

KORONADAL CITY, South Cotabato — The municipal government of Tampakan in South Cotabato has created a task force to prepare for the possible effects of Super El Niño, including drought, water shortages and damage to agricultural production. Mayor Leonard T. Escobillo issued Executive Order No. 37, series of 2026, creating the Tampakan El Niño Response

NFA steps up palay buying as buffer stock in Negros Occidental drops
Oct 22, 2026
NFA steps up palay buying as buffer stock in Negros Occidental drops

BACOLOD CITY — The National Food Authority (NFA) in Negros Occidental has intensified its palay procurement program to bolster its dwindling buffer stock, an official said on Thursday, Oct. 22. NFA Negros Occidental Branch Manager Cherrybeth Gevero said  their buffer stock has critically dropped to one-day supply, far below the agency’s mandated 15-day reserve. To

At least 16 dead in Tibet quake: China state media
Oct 22, 2026
At least 16 dead in Tibet quake: China state media

At least 16 people were killed and 32 more injured when a strong 7.0-magnitude earthquake struck China's remote Tibet region, state news agency Xinhua said, citing local authorities.

PH risks losing ₱603B yearly to money mule fraud, report warns
Oct 22, 2026
PH risks losing ₱603B yearly to money mule fraud, report warns

MANILA, Philippines — The Philippines could lose up to P603 billion annually, or nearly 3% of its gross domestic product (GDP), to fraud involving money mule accounts, according to a joint whitepaper by trust tech company IDfy Philippines and Filipino credit bureau CIBI Information Inc. The report, “Mule Hunting: Are We Chasing Ghosts?,” examined Bangko

No bribes or assurances: Marvic Leonen sets vision of the judiciary
Oct 22, 2026
No bribes or assurances: Marvic Leonen sets vision of the judiciary

MANILA, Philippines — Refusing to compromise his independence in his bid for the top judicial post, Senior Associate Justice Marvic Leonen, during his public interview before the Judicial and Bar Council (JBC) underscored that high office must never come at the expense of judicial integrity. “I give no bribe or assurance to anyone about any

Part 2: Old-timer bets in the running to be Marcos’ 2nd SC justice
Oct 22, 2026
Part 2: Old-timer bets in the running to be Marcos’ 2nd SC justice

These bets are part of the list of candidates who vied for the justice post in 2025 that ultimately went to Associate Justice Raul Villanueva

What's new in Singapore? Fresh spots to eat, experience, and explore
Oct 22, 2026
What's new in Singapore? Fresh spots to eat, experience, and explore

Upon landing in the Little Red Dot, you'll be greeted by the world-class Changi Airport, named the World's Best Airport for 2026 by Skytrax for a second year in a row.

Teacher charged with sexually abusing pupils, but were warning signs missed for years?
Oct 22, 2026
Teacher charged with sexually abusing pupils, but were warning signs missed for years?

Mkini's probe finds alleged disturbing lack of action over the years.

Dengue fatalities in Negros Occidental rise to 23
Oct 22, 2026
Dengue fatalities in Negros Occidental rise to 23

BACOLOD CITY — Dengue-related fatalities in Negros Occidental have climbed to 23 as total infections reached 4,208,  the Provincial Health Office (PHO) reported Thursday, Oct. 22. The figures from January 4 to October 17 show an overall drop of 17.57 percent or 879 fewer cases compared to the 5,105 cases reported during the same period

SWS: Fewer Filipinos follow Duterte trial than past impeachments
Oct 22, 2026
SWS: Fewer Filipinos follow Duterte trial than past impeachments

MANILA, Philippines — Fewer Filipinos closely followed the impeachment trial of Vice President Sara Duterte compared with past impeachment proceedings, the Social Weather Stations (SWS) reported. According to its survey conducted from Sept. 21 to 27, only 42 percent of adult Filipinos followed Duterte’s impeachment trial “very or somewhat” closely. The SWS said this was

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Voice of KL

We may be unheard, but things are different now. Voice of KL represents the voice of Malaysians who want you to discover the beautiful and developed city of Malaysia.